• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过PPARA进行表观遗传调控的基因抑制可增强肝细胞增殖。

Gene repression through epigenetic modulation by PPARA enhances hepatocellular proliferation.

作者信息

Aibara Daisuke, Takahashi Shogo, Yagai Tomoki, Kim Donghwan, Brocker Chad N, Levi Moshe, Matsusue Kimihiko, Gonzalez Frank J

机构信息

Laboratory of Metabolism, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Faculty of Pharmaceutical Science, Fukuoka University, 8-19-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan.

出版信息

iScience. 2022 Apr 4;25(5):104196. doi: 10.1016/j.isci.2022.104196. eCollection 2022 May 20.

DOI:10.1016/j.isci.2022.104196
PMID:35479397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9036120/
Abstract

Peroxisome proliferator-activated receptor α (PPARA) is a key mediator of lipid metabolism and inflammation. Activation of PPARA in rodents causes hepatocyte proliferation, but the underlying mechanism is poorly understood. This study focused on genes repressed by PPARA and analyzed the mechanism by which PPARA promotes hepatocyte proliferation in mice. Activation of PPARA by agonist treatment was autoregulated, and induced expression of the epigenetic regulator UHRF1 via activation of the newly described PPARA target gene , which, in turn, regulates . UHRF1 strongly repressed the expression of CDH1 via methylation of the promoter marked with H3K9me3. Repression of CDH1 by PPARA activation was reversed by PPARA deficiency or knockdown of E2F8 or UHRF1. Furthermore, a forced expression of CDH1 inhibited expression of the Wnt signaling target genes such as after PPARA activation, and suppressed hepatocyte hyperproliferation. These results demonstrate that the PPARA-E2F8-UHRF1-CDH1 axis causes epigenetic regulation of hepatocyte proliferation.

摘要

过氧化物酶体增殖物激活受体α(PPARA)是脂质代谢和炎症的关键调节因子。在啮齿动物中,PPARA的激活会导致肝细胞增殖,但其潜在机制尚不清楚。本研究聚焦于受PPARA抑制的基因,并分析了PPARA促进小鼠肝细胞增殖的机制。通过激动剂处理激活PPARA是自动调节的,并通过激活新描述的PPARA靶基因诱导表观遗传调节因子UHRF1的表达,而该靶基因又调节……UHRF1通过对标记有H3K9me3的启动子进行甲基化,强烈抑制CDH1的表达。PPARA激活对CDH1的抑制作用可通过PPARA缺陷或E2F8或UHRF1的敲低而逆转。此外,在PPARA激活后,强制表达CDH1会抑制Wnt信号靶基因(如……)的表达,并抑制肝细胞过度增殖。这些结果表明,PPARA-E2F8-UHRF1-CDH1轴导致肝细胞增殖的表观遗传调控。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e61/9036120/dd64f5c51036/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e61/9036120/bc58dc9b0cde/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e61/9036120/6e5015f2ddec/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e61/9036120/d079e701ddad/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e61/9036120/e4435290364d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e61/9036120/a3b5cbc91990/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e61/9036120/682686f6e9be/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e61/9036120/86123bb01277/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e61/9036120/dd64f5c51036/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e61/9036120/bc58dc9b0cde/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e61/9036120/6e5015f2ddec/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e61/9036120/d079e701ddad/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e61/9036120/e4435290364d/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e61/9036120/a3b5cbc91990/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e61/9036120/682686f6e9be/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e61/9036120/86123bb01277/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9e61/9036120/dd64f5c51036/gr7.jpg

相似文献

1
Gene repression through epigenetic modulation by PPARA enhances hepatocellular proliferation.通过PPARA进行表观遗传调控的基因抑制可增强肝细胞增殖。
iScience. 2022 Apr 4;25(5):104196. doi: 10.1016/j.isci.2022.104196. eCollection 2022 May 20.
2
[Epigenetic Regulation of Gene Expression and Hepatocyte Proliferation by Nuclear Receptor PPARA].[核受体PPARA对基因表达和肝细胞增殖的表观遗传调控]
Yakugaku Zasshi. 2024;144(2):157-161. doi: 10.1248/yakushi.23-00176.
3
Hepatocyte-specific PPARA expression exclusively promotes agonist-induced cell proliferation without influence from nonparenchymal cells.肝细胞特异性PPARA表达仅促进激动剂诱导的细胞增殖,不受非实质细胞的影响。
Am J Physiol Gastrointest Liver Physiol. 2017 Mar 1;312(3):G283-G299. doi: 10.1152/ajpgi.00205.2016. Epub 2017 Jan 12.
4
Keratin 23 Is a Peroxisome Proliferator-Activated Receptor Alpha-Dependent, MYC-Amplified Oncogene That Promotes Hepatocyte Proliferation.角蛋白 23 是过氧化物酶体增殖物激活受体 α 依赖性、MYC 扩增的癌基因,可促进肝细胞增殖。
Hepatology. 2019 Jul;70(1):154-167. doi: 10.1002/hep.30530. Epub 2019 Mar 20.
5
Myeloid peroxisome proliferator-activated receptor α deficiency accelerates liver regeneration via IL-6/STAT3 pathway after 2/3 partial hepatectomy in mice.在小鼠2/3部分肝切除术后,髓样过氧化物酶体增殖物激活受体α缺乏通过IL-6/STAT3途径加速肝脏再生。
Hepatobiliary Surg Nutr. 2022 Apr;11(2):199-211. doi: 10.21037/hbsn-20-688.
6
Functional microRNA high throughput screening reveals miR-9 as a central regulator of liver oncogenesis by affecting the PPARA-CDH1 pathway.功能性微小RNA高通量筛选揭示,miR-9通过影响PPARA-CDH1信号通路,成为肝脏肿瘤发生的核心调节因子。
BMC Cancer. 2015 Jul 24;15:542. doi: 10.1186/s12885-015-1562-9.
7
Hepatocyte Peroxisome Proliferator-Activated Receptor α Enhances Liver Regeneration after Partial Hepatectomy in Mice.肝细胞过氧化物酶体增殖物激活受体 α 增强小鼠肝部分切除术后的肝再生。
Am J Pathol. 2019 Feb;189(2):272-282. doi: 10.1016/j.ajpath.2018.10.009. Epub 2018 Nov 16.
8
Hepatocyte peroxisome proliferator-activated receptor α regulates bile acid synthesis and transport.肝细胞过氧化物酶体增殖物激活受体α调节胆汁酸的合成与转运。
Biochim Biophys Acta Mol Cell Biol Lipids. 2019 Oct;1864(10):1396-1411. doi: 10.1016/j.bbalip.2019.05.014. Epub 2019 Jun 10.
9
Intestinal PPARα Protects Against Colon Carcinogenesis via Regulation of Methyltransferases DNMT1 and PRMT6.肠型过氧化物酶体增殖物激活受体 α 通过调控甲基转移酶 DNMT1 和 PRMT6 预防结肠癌发生。
Gastroenterology. 2019 Sep;157(3):744-759.e4. doi: 10.1053/j.gastro.2019.05.057. Epub 2019 May 30.
10
Hepatic global DNA and peroxisome proliferator-activated receptor alpha promoter methylation are altered in peripartal dairy cows fed rumen-protected methionine.在饲喂瘤胃保护性蛋氨酸的围产期奶牛中,肝脏整体DNA和过氧化物酶体增殖物激活受体α启动子甲基化发生改变。
J Dairy Sci. 2016 Jan;99(1):234-44. doi: 10.3168/jds.2015-10157. Epub 2015 Nov 14.

引用本文的文献

1
PPARɑ variant V227A reduces plasma triglycerides through enhanced lipoprotein lipolysis.过氧化物酶体增殖物激活受体α变体V227A通过增强脂蛋白脂解作用降低血浆甘油三酯水平。
J Lipid Res. 2025 May;66(5):100806. doi: 10.1016/j.jlr.2025.100806. Epub 2025 Apr 15.
2
Single-nucleus multiomic analysis of Beckwith-Wiedemann syndrome liver reveals PPARA signaling enrichment and metabolic dysfunction.贝克威思-维德曼综合征肝脏的单核多组学分析揭示了PPARA信号富集和代谢功能障碍。
Commun Biol. 2025 Mar 26;8(1):495. doi: 10.1038/s42003-025-07961-9.
3
Study on the anti-atherosclerosis mechanisms of Tanyu Tongzhi formula based on network pharmacology, Mendelian randomization, and experimental verification.

本文引用的文献

1
Feedback repression of PPARα signaling by Let-7 microRNA.Let-7 微 RNA 对 PPARα 信号的反馈抑制。
Cell Rep. 2021 Aug 10;36(6):109506. doi: 10.1016/j.celrep.2021.109506.
2
Programmed PPAR-α downregulation induces inflammaging by suppressing fatty acid catabolism in monocytes.程序性PPAR-α下调通过抑制单核细胞中的脂肪酸分解代谢诱导炎症衰老。
iScience. 2021 Jun 24;24(7):102766. doi: 10.1016/j.isci.2021.102766. eCollection 2021 Jul 23.
3
Suppressing the intestinal farnesoid X receptor/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis.
基于网络药理学、孟德尔随机化和实验验证的探讨痰瘀同治方抗动脉粥样硬化机制的研究。
Pharm Biol. 2024 Dec;62(1):790-802. doi: 10.1080/13880209.2024.2415666. Epub 2024 Oct 25.
4
Spatial Transcriptomic Study Reveals Heterogeneous Metabolic Adaptation and a Role of Pericentral PPARα/CAR/Ces2a Axis During Fasting in Mouse Liver.空间转录组学研究揭示了小鼠肝脏在禁食过程中代谢的异质性适应以及中央区 PPARα/CAR/Ces2a 轴的作用。
Adv Sci (Weinh). 2024 Nov;11(41):e2405240. doi: 10.1002/advs.202405240. Epub 2024 Sep 5.
5
A two-step strategy to expand primary human hepatocytes in vitro with efficient metabolic and regenerative capacities.两步法策略扩增具有高效代谢和再生能力的原代人肝细胞。
Stem Cell Res Ther. 2024 Sep 4;15(1):281. doi: 10.1186/s13287-024-03911-0.
6
Loss of PPARα function promotes epigenetic dysregulation of lipid homeostasis driving ferroptosis and pyroptosis lipotoxicity in metabolic dysfunction associated Steatotic liver disease (MASLD).过氧化物酶体增殖物激活受体α(PPARα)功能丧失会促进脂质稳态的表观遗传失调,从而在代谢功能障碍相关脂肪性肝病(MASLD)中引发铁死亡和焦亡脂毒性。
Front Mol Med. 2024 Jan 8;3:1283170. doi: 10.3389/fmmed.2023.1283170. eCollection 2023.
7
Exploring the Mechanisms of Sanguinarine in the Treatment of Osteoporosis by Integrating Network Pharmacology Analysis and Deep Learning Technology.通过整合网络药理学分析和深度学习技术探索血根碱治疗骨质疏松症的机制
Curr Comput Aided Drug Des. 2025;21(1):83-93. doi: 10.2174/0115734099282231240214095025.
8
Inhibition of AHCY impedes proliferation and differentiation of mouse and human adipocyte progenitor cells.AHCY 抑制可阻碍小鼠和人脂肪祖细胞的增殖和分化。
Adipocyte. 2024 Dec;13(1):2290218. doi: 10.1080/21623945.2023.2290218. Epub 2023 Dec 8.
9
Accumulation of Linoleic Acid by Altered Peroxisome Proliferator-Activated Receptor-α Signaling Is Associated with Age-Dependent Hepatocarcinogenesis in Transgenic Mice.过氧化物酶体增殖物激活受体-α信号改变导致亚油酸蓄积与转基因小鼠年龄依赖性肝癌发生相关。
Metabolites. 2023 Aug 10;13(8):936. doi: 10.3390/metabo13080936.
10
PPARα Induces the Expression of CAR That Works as a Negative Regulator of PPARα Functions in Mouse Livers.过氧化物酶体增殖物激活受体α诱导细胞色素 P450 家族成员 4 表达,后者作为负调节剂在小鼠肝脏中发挥作用。
Int J Mol Sci. 2023 Feb 16;24(4):3953. doi: 10.3390/ijms24043953.
抑制肠道法尼醇 X 受体/鞘磷脂磷酸二酯酶 3 轴可减少动脉粥样硬化。
J Clin Invest. 2021 May 3;131(9). doi: 10.1172/JCI142865.
4
PPARα Ligand-Binding Domain Structures with Endogenous Fatty Acids and Fibrates.具有内源性脂肪酸和贝特类药物的PPARα配体结合域结构
iScience. 2020 Oct 23;23(11):101727. doi: 10.1016/j.isci.2020.101727. eCollection 2020 Nov 20.
5
Long non-coding RNA Gm15441 attenuates hepatic inflammasome activation in response to PPARA agonism and fasting.长链非编码 RNA Gm15441 可减弱过氧化物酶体增殖物激活受体激动剂和禁食诱导的肝炎症小体激活。
Nat Commun. 2020 Nov 17;11(1):5847. doi: 10.1038/s41467-020-19554-7.
6
PPARα and NCOR/SMRT corepressor network in liver metabolic regulation.过氧化物酶体增殖物激活受体 α 与核受体辅抑制因子/沉默调节蛋白复合抑制因子在肝脏代谢调控中的作用网络
FASEB J. 2020 Jul;34(7):8796-8809. doi: 10.1096/fj.202000055RR. Epub 2020 May 12.
7
Cell cycle oscillators underlying orderly proteolysis of E2F8.细胞周期振荡器是 E2F8 有序蛋白水解的基础。
Mol Biol Cell. 2020 Apr 1;31(8):725-740. doi: 10.1091/mbc.E19-12-0725. Epub 2020 Jan 29.
8
Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials.靶向癌症治疗的表观遗传调节剂:机制和临床试验进展。
Signal Transduct Target Ther. 2019 Dec 17;4:62. doi: 10.1038/s41392-019-0095-0. eCollection 2019.
9
Identification of E2F8 as a Transcriptional Regulator of Gluconeogenesis in Primary Mouse Hepatocytes.鉴定 E2F8 作为原代小鼠肝细胞糖异生的转录调节剂。
Biochemistry (Mosc). 2019 Dec;84(12):1529-1536. doi: 10.1134/S0006297919120125.
10
Epigenetic Mechanisms of the Glucocorticoid Receptor.糖皮质激素受体的表观遗传机制。
Trends Endocrinol Metab. 2019 Nov;30(11):807-818. doi: 10.1016/j.tem.2019.07.003.